AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 61 filers reported holding AVROBIO INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $331,000 | -77.4% | 23,449 | -73.9% | 0.01% | -78.0% |
| Q2 2019 | $1,463,000 | -33.7% | 90,000 | -10.0% | 0.06% | -34.4% |
| Q1 2019 | $2,205,000 | +32.4% | 100,000 | 0.0% | 0.09% | +45.2% |
| Q4 2018 | $1,665,000 | -67.9% | 100,000 | 0.0% | 0.06% | -54.1% |
| Q3 2018 | $5,187,000 | +45.3% | 100,000 | -20.0% | 0.14% | +77.6% |
| Q2 2018 | $3,570,000 | – | 125,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 2,736,027 | $45,555,000 | 28.05% |
| Aisling Capital Management LP | 736,998 | $12,271,000 | 12.93% |
| Cormorant Asset Management, LP | 1,357,784 | $22,607,000 | 1.84% |
| New Leaf Venture Partners, L.L.C. | 215,550 | $3,589,000 | 0.98% |
| Eventide Asset Management | 928,891 | $14,901,000 | 0.66% |
| EMERALD ADVISERS, LLC | 380,636 | $6,338,000 | 0.31% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 372,865 | $6,208,000 | 0.29% |
| Blackstone Inc. | 2,962,325 | $49,323,000 | 0.28% |
| PFM Health Sciences, LP | 241,413 | $4,020,000 | 0.11% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 143,762 | $2,394,000 | 0.10% |